Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosa.

Mdluli KE, Witte PR, Kline T, Barb AW, Erwin AL, Mansfield BE, McClerren AL, Pirrung MC, Tumey LN, Warrener P, Raetz CR, Stover CK.

Antimicrob Agents Chemother. 2006 Jun;50(6):2178-84.

2.

Potent, novel in vitro inhibitors of the Pseudomonas aeruginosa deacetylase LpxC.

Kline T, Andersen NH, Harwood EA, Bowman J, Malanda A, Endsley S, Erwin AL, Doyle M, Fong S, Harris AL, Mendelsohn B, Mdluli K, Raetz CR, Stover CK, Witte PR, Yabannavar A, Zhu S.

J Med Chem. 2002 Jul 4;45(14):3112-29.

PMID:
12086497
3.

Antimicrobial effects of novel siderophores linked to beta-lactam antibiotics.

Kline T, Fromhold M, McKennon TE, Cai S, Treiberg J, Ihle N, Sherman D, Schwan W, Hickey MJ, Warrener P, Witte PR, Brody LL, Goltry L, Barker LM, Anderson SU, Tanaka SK, Shawar RM, Nguyen LY, Langhorne M, Bigelow A, Embuscado L, Naeemi E.

Bioorg Med Chem. 2000 Jan;8(1):73-93.

PMID:
10968267
4.
6.

A class III transcription factor composed of RNA.

Young LS, Dunstan HM, Witte PR, Smith TP, Ottonello S, Sprague KU.

Science. 1991 Apr 26;252(5005):542-6.

PMID:
1708526

Supplemental Content

Loading ...
Support Center